{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T08:37:25Z","timestamp":1762504645758},"reference-count":12,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2001,8,1]],"date-time":"2001-08-01T00:00:00Z","timestamp":996624000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2001,8]]},"DOI":"10.1006\/gyno.2001.6272","type":"journal-article","created":{"date-parts":[[2002,9,17]],"date-time":"2002-09-17T18:50:18Z","timestamp":1032288618000},"page":"323-328","source":"Crossref","is-referenced-by-count":83,"title":["Liposomal Doxorubicin in Ovarian, Peritoneal, and Tubal Carcinoma: A Retrospective Comparative Study of Single-Agent Dosages"],"prefix":"10.1006","volume":"82","author":[{"given":"Peter G.","family":"Rose","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Hawthorne Maxson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy","family":"Fusco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kim","family":"Mossbruger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1006\/gyno.2001.6272_RF1","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1200\/JCO.1997.15.3.987","article-title":"Phase II study of liposomal doxorubicin in refractory ovarian cancer: antitumor activity and toxicity modification by liposomal encapsulation","volume":"15","author":"Muggia","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1006\/gyno.2001.6272_RF2","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.1200\/JCO.2000.18.17.3093","article-title":"Phase II study of stealth liposomal doxorubicin (Doxil) in platinum and paclitaxel refractory epithelial ovarian cancer","volume":"18","author":"Gordon","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1006\/gyno.2001.6272_RF3","first-page":"380a","article-title":"Interim analysis of a phase III randomized trial of Doxil\/Caelyx (D) versus topotecan (T) in the treatment of patients with relapsed ovarian cancer","volume":"19","author":"Gordon","year":"2000","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.1006\/gyno.2001.6272_RF4","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1006\/gyno.2000.5921","article-title":"Phase 2 trial of liposomal doxorubicin (40 mg\/m2) in platinum\/paclitaxel-refractory ovarian and fallopian tube cancers and primary carcinoma of the peritoneum","volume":"78","author":"Markman","year":"2000","journal-title":"Gynecol Oncol"},{"key":"10.1006\/gyno.2001.6272_RF5","first-page":"1434a","article-title":"A retrospective analysis of the clinical utility of liposomal doxorubicin in recurrent ovarian cancer (ROC)","volume":"18","author":"Campos","year":"1999","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.1006\/gyno.2001.6272_RF6","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1023\/A:1008240421028","article-title":"Predictors of response to subsequent chemotherapy in platinum pretreated ovarian cancer: a multivariate analysis of 704 patients","volume":"8","author":"Eisenhauer","year":"1997","journal-title":"Ann Oncol"},{"key":"10.1006\/gyno.2001.6272_RF7","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/1097-0142(20010101)91:1<90::AID-CNCR12>3.0.CO;2-A","article-title":"Treatment of patients with ovarian cancer with pegylated liposomal doxorubicin: analysis of toxicities and predictors of outcome","volume":"91","author":"Safra","year":"2001","journal-title":"Cancer"},{"key":"10.1006\/gyno.2001.6272_RF8","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1200\/JCO.1996.14.5.1545","article-title":"Defining response of ovarian carcinoma to initial chemotherapy according to serum CA-125","volume":"14","author":"Rustin","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1006\/gyno.2001.6272_RF9","first-page":"356a","article-title":"Randomized phase III study of cisplatin (CIS) paclitaxel (PAC) versus carboplatin (CARBO)\/PAC in optimal stage III epithelial ovarian cancer (OC): a Gynecologic Oncology Group trial","volume":"18","author":"Ozols","year":"1999","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.1006\/gyno.2001.6272_RF10","first-page":"356a","article-title":"Cisplatin\/paclitaxel vs carboplatin\/paclitaxel in ovarian cancer: update of an Arbeitsgemeinschaft Gynakologische Okologie (AGO) study group trial","volume":"18","author":"DuBois","year":"1999","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.1006\/gyno.2001.6272_RF11","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1634\/theoncologist.5-1-26","article-title":"Second-line treatment of ovarian cancer","volume":"5","author":"Markman","year":"2000","journal-title":"Oncologist"},{"key":"10.1006\/gyno.2001.6272_RF12","first-page":"1233","article-title":"Stabilization of disease as a useful predictor of survival following second-line chemotherapy in small cell lung cancer and ovarian cancer patients","volume":"15","author":"Cesano","year":"1999","journal-title":"Int J Oncol"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825801962729?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825801962729?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,8]],"date-time":"2019-05-08T06:21:09Z","timestamp":1557296469000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825801962729"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,8]]},"references-count":12,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2001,8]]}},"alternative-id":["S0090825801962729"],"URL":"https:\/\/doi.org\/10.1006\/gyno.2001.6272","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2001,8]]}}}